SM
Serina Magner Fischer
About Serina Magner Fischer
Data last updated:
Serina Magner Fischer was a Director at Takeda Biopharmaceuticals India Private Limited (2022–2024), Director at Shire Biotech India Private Limited (from 2022) and Director at Takeda Pharmaceuticals India Private Limited (from 2022). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Takeda Biopharmaceuticals India Private Limited U51909HR2015FTC055144 | Director | 15 Mar 2022 | 2015 | ₹727 Cr (FY 2025) | Active |
 Shire Biotech India Private Limited U51909HR2017FTC070872 | Director | 16 Mar 2022 | 2017 | ₹13.91 Cr (FY 2022) | Amalgamated |
 Takeda Pharmaceuticals India Private Limited U24239MH2011FTC212891 | Director | 17 Mar 2022 | 2011 | ₹8.48 Cr (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Serina Magner Fischer
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serina Magner Fischer
Serina Magner Fischer was first appointed on 15 Mar 2022 as Director at Takeda Biopharmaceuticals India Private Limited.
Serina Magner Fischer held 3 earlier board appointments: Takeda Biopharmaceuticals India Private Limited (Director, 15 Mar 2022 to 15 May 2024); Shire Biotech India Private Limited (Director, from 16 Mar 2022); Takeda Pharmaceuticals India Private Limited (Director, from 17 Mar 2022).